Company intelligence / Profile preview

Ardeypharm

Herdecke, Nordrhein-Westfalen, Germanyardeypharm.com ↗

Ownership: Private
Development stage: Other

Overview

Ardeypharm specializes in the development, manufacturing, and commercialization of probiotic drugs—most notably Mutaflor®, which contains the unique non-pathogenic Escherichia coli strain Nissle 1917. The company also offers a range of chemically defined pharmaceuticals and herbal remedies targeting gastrointestinal health. Their R&D has a strong focus on the human intestinal microbiota's role in health, with collaborations involving hospitals and universities worldwide. Their lead probiotic drug has established clinical evidence supporting its use in various GI conditions.[1][2][4]

Therapeutic areas: GastroenterologyMetabolic DisordersInfectious Diseases
Modalities: Live biotherapeutic product therapySmall moleculeHerbal remedy
Industry: Biotech

Drug pipeline

8 assets

lactobacillus acidophilus

7 more assets in the full pipeline.

Request access →

Partnerships

Collaborations with hospitals and universities globally for R&D purposes

Beyond the preview

Go deeper on Ardeypharm.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ardeypharm.

Explore the full profile